These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9062141)

  • 21. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
    Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
    Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
    Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
    Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
    Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma.
    Miyamoto T; Watanabe J; Hata H; Jobo T; Kawaguchi M; Hattori M; Saito M; Kuramoto H
    J Steroid Biochem Mol Biol; 2004 Oct; 92(3):111-8. PubMed ID: 15555905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steroid receptor expressions in endometrial cancer: clinical significance and epidemiological implication.
    Jeon YT; Park IA; Kim YB; Kim JW; Park NH; Kang SB; Lee HP; Song YS
    Cancer Lett; 2006 Aug; 239(2):198-204. PubMed ID: 16168561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: possible role in AP-1-mediated proliferation of ER-negative endometrial cancer.
    Fournier DB; Chisamore M; Lurain JR; Rademaker AW; Jordan VC; Tonetti DA
    Gynecol Oncol; 2001 Jun; 81(3):366-72. PubMed ID: 11371124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quantitative determination with image analysis of immunohistochemically identified steroid hormone receptors in breast carcinoma].
    Mink D; Uhrmacher S; Heiss C; Villena-Heinsen C; Schmidt W
    Geburtshilfe Frauenheilkd; 1995 Jan; 55(1):17-22. PubMed ID: 7705593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
    Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
    Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of estrogen and progesterone receptors and oncoprotein HER-2 as a marker for clinical course and outcome in endometrioid adenocarcinoma of the uterine body (immunohistologic study)].
    Samsonova EA; Maksimova NA; Urmancheeva AF; Pozharisskiĭ KM
    Vopr Onkol; 2004; 50(2):196-201. PubMed ID: 15176223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression analysis of the estrogen and progesterone receptors in endometrial carcinomas.
    Olech-Fudali E; Chibowski D; Skomra D; Walczyna B
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():319-25. PubMed ID: 11977333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
    Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
    Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of estrogen receptor expression in endometrial cancer specimens to bone mineral density.
    Douchi T; Tsuji T; Tokuhisa T; Fujie Y; Katanozaka M; Yoshinaga M; Nagata Y
    Acta Obstet Gynecol Scand; 2000 Nov; 79(11):1011-4. PubMed ID: 11081689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of estrogen receptor and progesterone receptor in colorectal cancer: a quantitative study].
    Zhou ZW; Wan DS; Wang GQ; Pan ZZ; Lu HP; Gao JH; Ding PR
    Ai Zheng; 2004 Jul; 23(7):851-4. PubMed ID: 15248927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature.
    Mariani A; Sebo TJ; Katzmann JA; Riehle DL; Dowdy SC; Keeney GL; Lesnick TG; Podratz KC
    Anticancer Res; 2005; 25(4):2921-7. PubMed ID: 16080545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue.
    Nephew KP; Choi CM; Polek TC; McBride R; Bigsby RM; Khan SA; Husseinzadeh N
    Gynecol Oncol; 2000 Mar; 76(3):388-96. PubMed ID: 10684716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C; Wejaranayang C; Vipupinyo C
    J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia.
    Vereide AB; Kaino T; Sager G; Arnes M; Ørbo A
    Gynecol Oncol; 2006 May; 101(2):214-23. PubMed ID: 16325240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.